反式度骨化醇
|
|
|
- CAS號:
- 74007-20-8
- 英文名:
- trans-Doxercalciferol
- 英文別名:
- (1α,3β,5E,7E,22E)-;trans-Doxercalciferol;Calcipotriol Impurity 16;Doxercalciferol Impurity 14;1α-hydroxy-5,6-trans-vitamin D2;1α-hydroxy-5,6-trans-vitamin D2;Doxercalciferol impurity 1/trans-Doxercalciferol;(1R,3S,E)-5 - ((E)-2 - ((1R,3AS,7AR)-1 - ((2R,5R,E;Doxercalciferol Impurity 9 (trans-Doxercalciferol);9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1a,3b,5E,7E,22E)
- 中文名:
- 反式度骨化醇
- 中文別名:
- 反式度骨化醇;度骨化醇N-1;度骨化醇雜質(zhì)14;反式度骨化醇前體;鈣泊三醇雜質(zhì)16;度骨化醇雜質(zhì)02;化合物 T13197;反式度骨化醇(USP雜質(zhì);度骨化醇 N-1 DCP; 反式-度骨化醇1Β-度骨化醇
- CBNumber:
- CB22509002
- 分子式:
- C28H44O2
- 分子量:
- 412.65
- MOL File:
- 74007-20-8.mol
|
|
|
反式度骨化醇化學(xué)性質(zhì)
-
沸點:
-
538.7±50.0 °C(Predicted)
-
|
-
密度:
-
1.01±0.1 g/cm3(Predicted)
-
|
-
儲存條件:
-
Store at -20°C
-
|
-
溶解度:
-
Chloroform (Slightly), Methanol (Slightly)
-
|
-
酸度系數(shù)(pKa):
-
14.43±0.40(Predicted)
-
|
-
形態(tài):
-
Solid
-
|
-
顏色:
-
White to Off-White
-
|
-
穩(wěn)定性:
-
Light Sensitive
-
|
反式度骨化醇性質(zhì)、用途與生產(chǎn)工藝
trans-Doxercalciferol 是 Doxercalciferol 的異構(gòu)體。Doxercalciferol 是一種維生素 D2 類似物，作為維生素 D 受體的激活劑，可以預(yù)防腎臟疾病。
反式度骨化醇
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
| 更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS編號 | 包裝 | 價格 |
|---|
| 2024/11/08 | HY-75992 | 反式度骨化醇
trans-Doxercalciferol | 74007-20-8 | 1mg | 2000元 |
| 2024/11/08 | HY-75992 | 反式度骨化醇
trans-Doxercalciferol | 74007-20-8 | 10 mM * 1 mLin DMSO | 6718元 |
74007-20-8, 反式度骨化醇 相關(guān)搜索:
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Chiral Reagents
- 390-度骨化醇
- 化工試劑
- 度骨化醇雜質(zhì)02
- 反式-度骨化醇1Β-度骨化醇
- 度骨化醇雜質(zhì)9(反式度骨化醇前體)
- 度骨化醇雜質(zhì)14
- 反式度骨化醇(USP雜質(zhì)
- (1R,3S,5E)-4-亞甲基-5-[(2E)-2-[(1R,3AS,7AR)-八氫-7A-甲基-1-[(1R,2E,4R)-1,4,5-三甲基-2-己烯-1-基]-4H-茚-4-亞基]亞乙基]-1,3-環(huán)己二醇
- 反式度骨化醇前體
- 度骨化醇 N-1 DCP
- 鈣泊三醇雜質(zhì)16
- 化合物 T13197
- 反式度骨化醇
- TRANS-DOXERCALCIFEROL[干冰運輸]
- 度骨化醇N-1
- (1R,3S,E)-5-((E)-2-((1R,3AS,7AR)-1-((2R,5R,E)-5,6-二甲基庚-3-烯-2-基己基)-7A-甲基-六氫-1H-茚-4(2H)-亞基)亞乙基)-4-亞甲基環(huán)己烷-1,3-二醇
- 74007-20-8
- (1R,3S,E)-5-(2-((1R,3aS,7aR,E)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
- Doxercalciferol Impurity 14
- 1α-hydroxy-5,6-trans-vitamin D2
- Calcipotriol Impurity 16
- 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1a,3b,5E,7E,22E)
- Doxercalciferol impurity 1/trans-Doxercalciferol
- 1α-hydroxy-5,6-trans-vitamin D2
- Doxercalciferol Impurity 9 (trans-Doxercalciferol)
- (1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
- (1R,3S,E)-5 - ((E)-2 - ((1R,3AS,7AR)-1 - ((2R,5R,E
- trans-Doxercalciferol
- 1,3-Cyclohexanediol, 4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-, (1R,3S,5E)-
- (1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-diMethylhept-3-en-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diol
- (1R,3S,5E)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-Methyl-1-[(1R,2E,4R)-1,4,5-triMethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol-d3
- (1α,3β,5E,7E,22E)-
- (1R,3S,5E)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-Methyl-1-[(1R,2E,4R)-1,4,5-triMethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol